New Drug Approvals Archive - October 2011
New Indication Approved: October 7, 2011
Juvisync (simvastatin and sitagliptin) Tablets
Date of Approval: October 7, 2011
Juvisync (simvastatin and sitagliptin) is an HMG-CoA reductase inhibitor (statin) and dipeptidyl peptidase-4 (DPP-4) inhibitor fixed dose combination for the treatment of high cholesterol and type 2 diabetes.
Combivent (albuterol and ipratropium)
New Formulation Approved: October 7, 2011
Ferriprox (deferiprone) Tablets
Date of Approval: October 14, 2011
Ferriprox (deferiprone) is an iron chelator indicated for the treatment of patients with transfusional iron overload due to thalassemia syndromes when current chelation therapy is inadequate.
New Dosage Regimen: October 19, 2011
Onfi (clobazam) Tablets
Date of Approval: October 21, 2011
Onfi (clobazam) is a benzodiazepine antiepileptic drug for the treatment of patients with Lennox-Gastaut syndrome (LGS).
Exparel (bupivacaine) Injectable Suspension
Date of Approval: October 28, 2011
Exparel (bupivacaine liposome injectable suspension) is a long-acting non-opioid local analgesic for the management of postsurgical pain.